Two’s a Company, Three’s a Crowd: A Review of Initiating or Switching to a Two-Drug Antiretroviral Regimen in Treatment-Naïve and Treatment-Experienced Patients Living with HIV-1

Two’s a Company, Three’s a Crowd: A Review of Initiating or Switching to a Two-Drug Antiretroviral Regimen in Treatment-Naïve and Treatment-Experienced Patients Living with HIV-1

Abstract Introduction As HIV has become a manageable chronic condition, a renewed and increased interest in challenging traditional three-drug HIV therapies and moving toward two-drug regimens (2DR) for initial or maintenance treatment in people living with HIV (PLWH) has developed. As PLWH are livi...

Full description

Bibliographic Details
Main Authors: Melissa Badowski, Sarah E. Pérez, David Silva, Andrea Lee
Format: Article
Language:English
Published: Adis, Springer Healthcare 2020-03-01
Series:Infectious Diseases and Therapy
Subjects:
Antiretroviral therapy
Dual therapy
HIV
HIV treatment
Two-drug regimen (2DR)
Online Access:https://doi.org/10.1007/s40121-020-00290-w

Internet

https://doi.org/10.1007/s40121-020-00290-w

Similar Items